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Abstract This review covers the methods that chemists have developed to 
access halogenated polycyclic structures from polyenes, by emulating 
Nature’s enzymatic machineries. From pioneering studies to the most 
recent developments, the different strategies, whether based on the use of 
standard reagents or on the design of specific ones, will be presented. 
Finally, asymmetric reactions and applications for the total synthesis of 
natural products will be exposed. 
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1 Introduction 
The intricate polycyclic structures that living organism produce 
have been a tremendous source of inspiration for chemists, 
often leading to the development of powerful synthetic 
methods. From this standpoint, the electrophilic cyclization of 
polyenes, as pioneered by Stork1 and Eschenmoser2 in the 50s, 
remain a striking example of chemists rivalling Nature in terms 
of efficiency and selectivity and constitute a landmark for the 
field of biomimetic synthesis.3 Halogenated derivatives4 
constitute a particular sub-class of polycyclic natural 
compounds which, because of their complex and original 
structures and their therapeutic potential,5 fueled the 
development of many synthetic methods.6 In Nature the 
synthesis of these molecules from linear terpenes is achieved 
through various enzymatic machineries,7 that, following initial 
halogenation of a trisubstituted alkene, can readily achieve 
halogen-induced carbocyclizations, oxy-halogenations or poly-
halogenations. Several of these transformations sometimes 
occur for the same substrate. For instance, the brominated 
terpenoid bromophycolide A,8 that exhibits three different 
bromination patterns (including a cyclic one) could basically 
arise from three distinct electrophilic brominations of a geranyl-
geranyl starting material (Scheme 1). Yet, what enzymes have 
evolved to achieve can raise complex chemo-, regio-, and 
stereoselectivity issues for the synthetic chemist, especially 
considering that all patterns could come from a common 
intermediate. 
 
Scheme 1 Schematic biosynthesis of bromophycolide A 
Indeed, the first step in the electrophilic bromination of a 
geranyl derivative 1 would lead to a key bridged halonium 
intermediate 2, which can evolve following different pathways 
(Scheme 2). Elimination of one proton would yield allylic 
halide 3 while nucleophilic opening by an external nucleophile 
(such as water or a halide) would give disubstituted product 4. 
Eventually, trapping by the proximal double bond would lead to 
6-membered carbocation 5 that can then follow various routes 
such as elimination, trapping or cascade process. This 
carbocyclization pathway, when not triggered by a suitable 
enzyme, is generally the most difficult to favor compared to the 
other two major options. 
It is important to note that for the halocyclization of a linear 
terpene, such as geranyl derivative 1, the relative cis-
configuration of the resulting cyclohexyl cation 5 is dictated by 
the configuration of the bridged halonium 2 since the cyclization 
would take place through an SN2-type mechanism on a 
preorganized (most often chair-like) transition state (Scheme 
3). 
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Scheme 2 General outline for the electrophilic halogenation of terpenes 
From there, the subsequent steps can occur in a stereospecific 
manner, in particular if a cascade cyclization ensues. This 
implies that if the initial halogenation is enantioselective all 
stereogenic centers formed afterwards can be controlled. It 
should be mentioned that Braddock in 2013 and later Burns in 
2017 demonstrated that an enantiospecific polyene cyclization 
could be achieved from such an enantiopure bromiranium ion.9 
However, the latter did not come from a direct bromination but 
was generated from the corresponding bromohydrin9a or 
bromochloride.9b  
 
Scheme 3 Stereospecificity of the cyclization step 
The aim of this review is to present the different methods that 
chemists have developed to efficiently initiate the direct 
halonium induced cyclization of polyenes, from seminal works 
to the most recent breakthroughs, including asymmetric 
variations and applications for the total synthesis of natural 
products.10  
2 Pioneering Studies 
In 1966, Van Tamelen reported that, unlike most terpene 
derivatives that would give bromohydrins under the same 
conditions, treatment of methyl farnesate 6 with NBS in a 
water/THF mixture also produced minor amounts of bromo-
cyclized products 7 and 8 (Scheme 4, eq. 1).11 These compounds 
were identified as the major components of a fraction 
representing 12-15% yield. After selective saponification and 
further purification, only 4-5% of this fraction were found to be 
the bicyclic products 7. A similar cyclization was observed in 
1975 by Nasipuri for the more nucleophilic m-anisyl derivative 
9a (Scheme 4, eq. 2), which led to tricycle 10a in 10% yield 
under the same conditions (the major products being the acyclic 
dibromohydrins).12 
 
Scheme 4 First examples of bromocyclization of polyenes mediated by NBS 
The following year Faulkner described the bromocyclization of 
geranyl acetate 11a using bromine (Scheme 5, eq. 1).13 The use 
of bromine along with tin(IV) bromide mostly led to 
dibrominated products although 16% of cyclized product 12a 
could be isolated. Instead of SnBr4, silver(I) tetrafluoroborate 
was used to scavenge the bromide ions responsible for the 
dibromination of the olefin allowed the yield to reach 20%. 
Applying this second protocol to geranylacetone 13 gave 
bicyclic enol ether 14 in 20% yield (Scheme 5, eq. 2). Hydrolysis 
of the enol, vinylation of the resulting ketone followed by acidic 
treatment eventually furnished 10-bromo--chamigrene (15). 
 
Scheme 5 Faulkner’s bromocyclization of geranyl acetate and total synthesis 
of 10-bromo--chamigrene 
These seminal studies showed that the total synthesis of 
halogenated polycyclic natural products could be achieved by a 
straightforward biomimetic strategy. Yet, they also highlighted 
that, while feasible using standard reagents such as Br2 or NBS, 
the bromocyclization pathway was not favored and would 
require some kind of additive (a silver salt for Faulkner) or 
specifically designed reagents to increase its efficiency.  
3 Use of Specific Reagents 
3.1 TetraBromoCyclohexadienOne (TBCO) 
As the initial electrophilic halogenation of the terminal double 
bond would yield a highly reactive cationic intermediate, to 
promote carbocyclization other species in the reaction need to 
be less nucleophilic than the internal olefin. Taking this into 
consideration, Kato proposed a combination of 2,4,4,6-
tetrabromo-2,5-cyclohexadienone 16 (TBCO) and an 
aluminum(III) halide to promote the bromocyclization of 
polyenes.14 The Lewis acid would trigger the generation of a 
bromonium ion along with aluminate complex 17 which is a 
rather poor nucleophile (Scheme 6, eq. 1). When applied to 
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geranyl cyanide 18, these conditions gave 15% of the 
bromocyclized products 19 (Scheme 6, eq. 2). In this setting, the 
nucleophilic trapping of the carbocation by a bromide only 
happens after the cyclization. In the absence of AlBr3, no 
cyclization took place and the dibromination of the terminal 
double bond of 18 occurred quantitavely.15 In contrast, the 
conditions reported by Van Tamelen (Scheme 4, eq. 1)11 only 
gave the corresponding bromohydrin. Additionally, if TBCO is 
used in conjunction with cetyltrimethylammonium bromide, 
only the dibromination takes place.16 
 
Scheme 6 Activation of TBCO with AlBr3 and bromocyclization of geranyl 
cyanide 
TBCO was also used for the biomimetic synthesis of natural 
products, which will be covered in the dedicated section below. 
3.2 Bis(pyridine)iodonium tetrafluoroborate 
Bis(pyridine)iodonium tetrafluoroborate was developed in 
1985 by Barluenga as a practical reagent for the 1,2-
iodofunctionalization of olefins,17 and it proved suitable for the 
iodocarbocyclization of several polyenes. When very simple 
dienes such as hexa-1,5-diene 20a and hepta-1,6-diene 20b 
were subjected to the Barluenga’s reagents and tetrafluoroboric 
acid the iodocyclization took place in a 6-endo or 6-exo fashion 
to give fluorocyclohexanes 21 or 22 respectively (Scheme 7).18 
While iodocarbocyclization had been previously described with 
molecular iodine in CCl4, it was limited to one 1,6-diene 
containing a central gem-dialkyl carbon. Under these conditions, 
20a and 20b only led to linear polyiodinated products.19 
 
Scheme 7 Iodocyclization of dienes 
When phenyl-geranyl ether 23 was submitted to Barluenga’s 
reagent, iodo-chromane 24 was obtained with an excellent 
yield.20 To explain the formation of 24 and other rearranged 
products the authors proposed that the iodocarbocyclization 
would initially lead to an oxetanium intermediate. Substrate 23 
would thus give 25 that can then yield 24 (Scheme 8, eq. 1). This 
protocol can even be applied to longer polyenes such as farnesyl 
derivative 26 to give tetracyclic tetrahydroquinoline 27 in 41% 
yield, in this case without rearrangement (Scheme 8, Eq.2). 
 
Scheme 8 Iodocyclization of geranyl and farnesyl derivatives with Barluenga’s 
reagent 
3.3 Use of Halodiethylsulfoniums 
3.4.1 Bromodiethylsulfonium Bromopentachloro 
antimonate (BDSB) 
For the development of bromodiethylsulfonium 
bromopentachloroantimonate (BDSB) in 2009, the group of 
Snyder hypothesized that a controlled polyene cyclization 
required a highly activated cationic bromonium source without 
any nucleophilic anionic species being present.21 For this 
purpose they chose to synthetize and study the reactivity of 
various bromosulfoniums salts and eventually selected BDSB. 
BDSB is obtained by reaction of Br2 with SbCl5 and Et2S in 1,2-
dichloroethane at –30 °C (Scheme 9),22 it is fairly convenient to 
isolate and can be stored for some time before being used. 
 
Scheme 9 Synthesis of BDSB. 
This specifically designed reagents turned out to give exquisite 
results in terms of chemoselectivity and yields on a very broad 
range of substrates, especially compared to the existing 
methods at that time (Table 1). Ten years later, it remains the 
gold standard for the racemic bromo-cyclization of polyenes. 
Electron-poor substrates such as geranyl cyanide 18 or geraniol 
esters 11a, b and carbonate 11c selectively gave the 
corresponding monocyclic products with excellent yields 
(entries 1–4). Stronger electron-withdrawing groups (CN, 
OCOCF3) favored a final elimination to give cyclohexenes 28 and 
29 (entries 1, 3), whereas internal nucleophilic trapping 
occurred for acetate 11a and carbonate 11c to give alcohol 12a 
(after hydrolysis) and cyclic carbonate 30, respectively (entries 
2, 4).  
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Table 1 Reactivity of BDSB with a variety of polyenes and comparison with other methods 
 
Entry Starting material Product 
Conditions (reagent, solvent) 
Yield (reaction temperature) (time) 
  
 
  
 
[a] Isolated as a mixture of alkene stereoisomers. [b] All yields deriving from this reagent were determined by NMR analysis using nitrobenzene as an internal standard since the 
desired material co-elutes with undesired side products. [c] Generated alongside some very minor diastereomers. [d] Yield includes partially cyclized material. [e] Complete 
cyclization promoted by the addition of CH3SO3H at the end of the reaction. 
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Homogeranic acid 31 and its t-butyl ester 32 reacted equally 
well to give 6,5-bicyclic lactone 33 (entries 5, 6). One striking 
feature of BDSB is that it can directly convert electron-rich 
substrates such as homogeranylphenyl derivatives 9b, c and 
even farnesyl substrate 34 to the fully cyclized products 10b, c 
and 35 without having to resort to an additional acidic 
treatment (entries 7–9).  
3.4.2 IDSI and CDSC 
Following the development of BDSB, the group of Snyder 
studied the synthesis of iodo- and chloro-variants of their 
reagent.23 Reaction of iodine with pentachloroantimonate and 
diethyl sulfide was optimized to allow the isolation of a chlorine-
bridged dimer that was termed IDSI (Scheme 9, eq. 1). This 
dimer was less stable than BDSB – a quick decomposition 
occurred at room temperature to give ICl, SbCl5 and Et2S – but 
suitable to carry out iodination reactions (see below). Following 
a similar protocol with chlorine gave chlorodiethylsulfonium 
hexachloroantimonate (CDSC), which was structurally 
analogous to BDSB (Scheme 9, eq. 2). 
 
Scheme 10 Synthesis of IDSI and CDSC. 
Despite its minor drawbacks, IDSI could be used for the 
cyclization of several polyenes (Table 2, entries 1–3). For 
electron-rich benzylgeranyl 9c, d and for benzylfarnesyl 34 the 
desired tri- and tetracycles 36c, d and 37 respectively were 
obtained in good yields (entries 1–3)., even though for the latter 
the final cyclization required the addition of methane sulfonic 
acid. Protected phenolic derivative 38 underwent a cascade 
cyclization process to give tricycle 39 (with the loss of one MOM 
group, entry 4), Electron-poor compounds such as nitrile 18, 
geranyl acetate 11a and carbonate E-11c reacted in a similar 
fashion to that observed with BDSB, yielding cyclohexenes 40, 
tertiary alcohol 41a and cyclic carbonate 42, respectively 
(entries 5–7). Finally, neryl carbonate Z-11c also reacted to give 
the trans, cis isomer 42’ in moderate yield, thus confirming the 
stereospecificity of the transformation (entry 8). 
The CDSC reagent could also be applied for various cyclizations, 
which, although the scope was more limited and the yields more 
modest, represented the first report of an ionic chloronium 
induced polyene cyclization (Table 3). Hence, 
homogeranylbenzene 9b gave the chlorinated tricycle 43b in 
46% yield (entry 1). The reagent also promoted the cyclization 
of electron-poor substrates such as geranyl acetate 11a to give 
44 (entry 2), or homogeranic acid 31 and its t-butyl ester 32, 
both yielding lactone 45 with modest yields (entries 3, 4). 
Table 2 Reactivity of IDSI with a variety of polyenes 
 
Entry Starting material 
Product, yield 
Temp., Time 
  
[a] Isolated as a 2:1 mixture of inseparable stereoisomers about the highlighted 
carbon atom favoring the drawn diastereoisomer. [b] MeSO3H (15 equiv.) added 
with 1 h of additional stirring to promote the final cyclization. [c] Produced as a 
8.5:1.4:1.0 mixture of tri, tetra and disubstituted alkene isomers. 
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Table 3 Reactivity of CDSC with a variety of polyenes 
 
Entry Starting material 
Product, yield 
Temp., Time 
  
[a] Isolated as a 1.0:1.0 mixture of inseparable stereoisomers. [b] Isolated as a 
2.2:1.0 mixture of separable diastereoisomers at the highlighted carbon favoring 
the drawn product. [c] Produced as a 4.0:1.0 mixture of separable diastereomers 
at the highlighted carbon favoring the drawn product. 
3.4 Miscellaneous 
3.4.1 Trimethylphenylammonium perbromide 
Trimethylphenylammonium perbromide (TMPAP) is a soluble 
and stable electrophilic bromination reagent,24 which has been 
used for the transannular bromocyclization of costunolide 46 
(Scheme 11).25 An excellent overall yield of 95% was obtained 
for the formation of tricyclic 47 as a mixture of olefin isomers 
with the major one (70%) being the exo-isomer. The use of 
TMPAP greatly increases the efficiency of the product formation 
compared to NBS, which had previously been reported to give a 
very complex mixture after reaction with the analogous 
dihydrocostunolide.26 Water was excluded to prevent the 
formation of the tertiary alcohol by nucleophilic trapping of the 
carbocation and pyridine was added to scavenge any strong acid 
that would lead to the corresponding proton-induced 
transannular cyclization.25  
 
Scheme 11 Transannular bromocyclization with TMPAP 
3.4.2 Vanadium bromoperoxidase 
Since the aforementioned bromocyclizations were modeled 
after Nature’s, it was somewhat tempting to try and reproduce 
those transformations using a halogenase enzyme as catalyst.27 
The group of Butler isolated and cloned a vanadium 
bromoperoxidase (V-BrPO) from red algae and submitted 
several linear terpenes to this enzyme in the presence of 
potassium bromide and hydrogen peroxide.28 Thus, geranyl 
acetate 11a gave a racemic mixture of endo- and exo-bromo-
cyclohexenes 48 in moderate yield (10-20%, Scheme 12, eq 1) 
and geranyl acetone 13 gave the racemic bicycle 14 (Scheme 12, 
eq 2) that was previously reported by Faulkner (Scheme 5, eq. 
2).13 
 
Scheme 12 Butler’s enzymatic bromocyclization of geranyl acetate and 
geranyl acetone 
3.4.3 Bromiranium 
Following the strategy of having a stabilized bromonium with a 
weakly coordinating anion, the group of Hennecke designed the 
synthesis of the (stable) bromiranium salt of adamantylidene 
adamantane with a BArF (tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate) counterion (Scheme 13).29 
This reagent promoted the bromination of phosphines and was 
also used for the bromocyclization of three homogeranylarene 
derivatives (9) to give the corresponding tricyclic products 10 
with modest to good yields. Hexamethyldisilazane was used to 
prevent the formation of the very strong acid HBArF that can 
induce cationic cyclization of the substrates. 
 
Scheme 13 Bromocyclization induced by a stable bromiranium (after column 
chromatography the products are obtained with ca 90% purity, yields in 
brackets are after recrystallization from acetone) 
3.4.4 Bis(tert-butylcarbonyloxy)iodobenzene/Triethyl-
silylbromide 
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In order to generate an electrophilic bromination species that 
would selectively trigger the cyclization of polyenes and 
suppress the formation of the unwanted linear brominated 
products, the group of Cariou screened various combinations of 
hypervalent iodine(III) reagents30 as oxidants with different 
bromide sources.31 The rather soluble bis(tert-
butylcarbonyloxy) iodobenzene was selected so the reaction 
could be run at low temperature (-78 °C) in nitroethane, thus 
preventing undesired side reactions, and because the oxidation 
of the bromide would liberate pivalate, a rather mediocre 
nucleophile that would not compete with the internal double 
bond. As for the bromide source, triethylsilylbromide was 
chosen because it was soluble and relatively easy to handle. 
Using this combination of reagents allowed to selectively 
promote the carbocyclization process of various 
homogeranylbenzenes 9 and, after treatment of the crude with 
a strong acid, the desired tricyclic products 10 were isolated in 
moderate to good yields (Scheme 14). 
 
Scheme 14 Iodine(III)/bromide induced cyclization of homogeranylbenzene 
derivatives. 
The reaction conditions could also be applied to geranylaryl 
derivatives 4 to give snyderol type bromocyclohexenes 49a, b 
or, if an o-phenol moiety was present, to an isocymobarbatol32 
like bromo-hexahydroxanthene 50a (Scheme 15). Additionally, 
homofarnesyl derivative 34 could be converted into tetracyclic 
compound 35, albeit with a modest yield.  
 
Scheme 15 Iodine(III)/bromide induced cyclization of geranyl and 
homofarnesyl substrates 
Finally, it is worth noting that while this combination of reagents 
specifically promotes the polyene cyclization process, the use of 
other iodine(III) reagents with other bromides,31 chlorides or 
iodides,33 rather leads to various possible linear halogenated 
products in a selective fashion. 
4. Use of N-Halo Amides 
4.1 Activation with a phosphorus derivative 
4.1.1 Phosphines 
A considerable breakthrough in the field of halocyclization of 
polyenes came in 2007 when Ishihara described the iodo- and 
bromo-cyclization of benzyl-geranyl derivatives using a 
combination of the corresponding N-halosuccinimide with a 
nucleophilic promoter such as a phosphine.34 In sharp contrast 
with what had previously been observed,11 reacting 
homogeranyltoluene 9f with NBS or NIS in dichloromethane in 
the presence of 30% of tri-n-butylphosphine allowed, after 
acidic treatment, the isolation of the desired iodo- (36f) and 
bromo (10f) tricycles in good to quantitative yields (Scheme 
16). Other phosphines and phosphites could also promote the 
reaction, with lower yields, but nucleophilic amines such as 
DBCO and DMAP were inefficient. 
 
Scheme 16 Halocyclization with NXS promoted by a phosphine 
Ishihara proposed that the nucleophilic activation of the N-
halosuccinimide by the phosphine would give phosphonium salt 
52 as the actual halogenation species that would then react with 
the polyenic substrates 9 (Scheme 17). The close vicinity 
between the nucleophilic promoter and the halogen in the active 
species was considered determinant for the development of an 
asymmetric version of this reaction by the same authors (see 
dedicated section below). Setting the absolute configuration of 
haliranium 53 then induces the configuration of the stereogenic 
centers formed during the subsequent stereospecific cyclization 
process. 
 
Scheme 17 Mechanism proposal for the nucleophilic activation of NXS 
4.1.2 Phosphite-urea 
The major drawbacks of Ishihara’s protocol were the need for 
high catalyst loading (up to 100 mol% for the asymmetric 
variant) and the inferior (in terms of yield and ee) results 
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obtained for the bromination reaction with NBS.34 In order to 
overcome these limitations they later designed bifunctionnal 
phosphite-urea catalyst 54 (Scheme 18).35 Its reaction with NBS 
or with the more reactive 1,3-dibromo-5,5-dimethylhydantoin 
(DBDMH) would give complex 55 that would simultaneously 
bear the phosphonium bromide reactive center and sequestrate 
the imidate to prevent unwanted side-reactions. In particular, 
addition of the imidate onto the phosphonium would be 
detrimental since it would liberate bromides that might lead to 
the formation of the dibromo products. 
 
Scheme 18 Dual activation of DBDMH with a phosphite-urea catalyst 
This carefully designed system allowed to perform the reaction 
with a low catalyst loading (0.5 mol%) and a high efficiency for 
several homogeranylarenes 9, yielding the desired tricyclic 
products 10 in the 90% yield range after full cyclization in acidic 
conditions (Scheme 19). 
 
Scheme 19 Bromocyclization with DBDMH and a phosphite-urea catalyst 
These conditions were subsequently applied to 2-
geranylphenols to give isocymobarbatol-like bromo-
hexahydroxanthenes.36 
4.1.3 Phosphoramidite 
Shortly after Ishihara’s report, McErlean disclosed the use of 
phosphoramidite (S)-TCPT (56) as a promoter for the 
monocyclization of various geranyl derivatives with NBS.37 In 
toluene the reaction led to the cyclohexene derivatives as major 
product in all cases (Scheme 20). In contrast to BDSB (see Table 
1), benzyl derivative 9b and acylgeraniols 11a, d afforded 
cyclohexenes 58b and 48a, d. Unfortunately, although the 
promoter is chiral, no optically active products could be isolated.  
 
Scheme 20 Bromocyclization with NBS promoted by a phosphoramidite. 
4.2 Activation with an amine 
While Ishihara had shown that neither DABCO nor DMAP were 
suitable activators, the group of Yamamoto briefly reported that 
2,4,6-trimethylaniline could promote the bromocyclization of 
9b into 10b in 66% yield (after acidic treatment).38 After this 
single example the group of Gulder recently showed that 
hexafluoroisopropanol (HFIP) had a dramatic positive effect for 
the halocyclization of polyenes using N-haloamides such as NBS 
(42% of 10b from 9b in HFIP vs 8% in DCM). Even better yields 
(78%) could be achieved in the presence of morpholine (as its 
HFIP salt).39 Using this simple setting a broad range of polyenes 
could undergo bromocyclization with excellent yields that 
compare favorably with those obtained with BDSB (Scheme 21).  
 
Scheme 21 Bromocyclization with NBS-morpholine in HFIP 
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Similar to BDSB (Table 1), tricycles 10 were directly obtained 
from the starting homogeranylarenes 9, the farnesyl derivative 
34 being the only one that required an additional acidic 
treatment to form tetracyclic product 35 (Scheme 21). 
Hexahydroxanthene 50a stemmed from the cyclization of o-
geranylphenol with one equivalent of NBS whereas the reaction 
with two equivalents of NBS induced an additional bromination 
of the aryl ring (product 57). The reaction of geraniol esters 
gave the monocyclized tertiary alcohols 12a, e-h with good 
yields and stereoselectivities, while geranyl cyanide furnished a 
mixture of cyclohexenes (28). Finally, homogeraniol and 
homogeranic acid underwent a cascade cyclization to give 
tetrahydrofuran 58 and lactone 32, respectively. 
This method was readily extended to the analogous 
iodocyclization with NIS, giving the desired products with good 
yields and diastereomeric ratios up to 95:5 (Scheme 22). 
Homogeranylarene substrates directly yielded the tricyclic 
compounds 36 while o-geranylphenol gave iodo-
hexahydroxanthene 59. Following the general trend observed 
for bromocyclization, geranyl esters gave tertiary cyclohexanols 
41a, g and geranylcyanide gave cyclohexene 40. If an internal 
nucleophile is present, a cascade cyclization takes place giving 
an additional oxygenated ring, either a carbonate (60) or an 
ether (61). 
 
Scheme 22 Iodocyclization with NIS-morpholine in HFIP 
One key feature of this morpholine-HFIP system is that it could 
also be applied for the chlorocyclization of polyenes, using 1,3-
dichloro-5,5-dimethylhydantoin (DCDMH) instead of NCS. 
Although the scope and the yields are modest it represents a 
major improvement as until then only the CSDC was known to 
promote this type of chlorocyclization. In addition to the 
tricyclic chloro-products 43, previously obtained by Snyder, 
tetracycle 61 and oxygenated tricycle 62 could also be 
synthetized (Scheme 23). 
Based on various mechanistic studies, the authors suggest 
several beneficial roles for the HFIP. First, as a strong hydrogen-
bond donor it would stabilize the N-halo morpholine species, 
that was proposed as key reactive intermediate for 
halocyclization. Moreover, its high polarity would induce a 
prearrangement of the polyene through hydrophobic 
interactions. The apolar hydrocarbon chain would thus adopt a 
tight chair-like conformation, readily poised for cyclization. 
 
Scheme 23 Chlorocyclization with DCDMH-morpholine in HFIP 
5. Asymmetric Reactions 
The direct halonium-induced cyclization of polyenes already 
being a challenge per se, rendering this transformation 
enantioselective was even more arduous.40 Despite many 
accomplishments for the asymmetric halofunctionalization of 
alkenes,41 including cyclizations42 and dihalogenation,43 the 
asymmetric cyclization of polyenes remained elusive until 2007 
and the work of Ishihara.3444 
5.1 Ishihara’s strategy 
5.1.1 Iodocyclization 
After successfully devising conditions to activate NIS with a 
phosphorous nucleophile for the direct iodocyclization of 
polyene, the group of Ishihara went further by probing chiral 
inductors for the asymmetric version.  
 
Scheme 24 Asymmetric iodocyclization of polyenes. 
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A binol-derived phosphoramidite 62 was found to be the best 
promoter. Using one equivalent of 62 in combination with NIS 
in toluene, tricycles 36b, c, k and tetracycle 63 were obtained in 
good yields (after acidic treatment) and with enantiomeric 
excesses up to 99% (Scheme 24). As mentioned previously, 
Ishihara’s mechanistic proposal stated that a phosphonium salt 
is the actual halogenation species. In toluene, reaction between 
NIS and promoter 62 would give a tight ion pair 64 which can 
be represented as 64’ in Newman projection along the P-I bond 
(Figure 1). In this view, three segments of space can be delimited 
depending on steric hindrance. Iodination of the most reactive 
prenyl double bond, within the least hindered space would take 
place by a Si-face approach leading to the observed S-
configuration in the final product. The subsequent stereocenters 
would be set during the following stereospecific cyclization 
process, whether it directly happens during the course of the 
reaction or only after treatment with a strong acid. 
 
Figure 1 Mechanistic rationale proposed by Ishihara to explain the 
stereoinduction during asymmetric iodocyclization 
5.1.2 Bromocyclization 
After successfully rendering the bromocyclization of polyenes 
catalytic by using a phosphite-urea bifunctionnal catalyst (54, 
Figure 2), the group of Ishihara reported an enantioselective 
version of their strategy.45 The catalyst backbone of 54 was 
expanded from a bi-phenyl to a bi-naphthyl and the 3,5-
diphenylphenyl substituents were exchanged for 3,5-
dipentafluorosulfanylphenyl groups (65). 
 
Figure 2 Ishihara’s chiral phosphite-urea catalyst 
Using 10 mol% of this catalyst 65 with N-bromophthalimide 
NBP (instead of the succinimide), cyclization of 2-
geranylphenols 66a-f afforded the monocyclized 
bromocyclohexenes 67a-f in good yields and moderate ee 
(Scheme 25). Tricycles 50a-e, 57 were also formed in the 
reaction and isolated in significantly lower yields and 
enantiomeric excess. 
 
Scheme 25 Asymmetric bromocyclization of geranylphenols 
However, when the monocyclic compounds 67 were converted 
to the tricyclic products 50, using triflic acid at low temperature 
in i-PrNO2 the enantiomeric excesses remained unchanged. This 
observation led the authors to assume that the single cyclization 
and the cascade cyclization did not arise from the same process, 
and the transition states involved were likely to be different. The 
major process, i.e. the monocyclization, would occur via TSmono 
(Figure 3). In this transition state, an H-bond is established 
between the phenol and the urea moiety. This stabilizes the TS 
and precludes O-cyclization, favoring the formation of the 
enantioenriched monocyclized product. The tricyclic products 
were proposed to arise from the less stable TScasc, where no 
hydrogen bond is present and the phenol is thus more 
nucleophilic. 
 
Figure 3 Comparison between mono-cyclization and cascade transition states 
5.2 Yamamoto’s Strategy 
Ten years after Ishihara’s group initial report34and taking cues 
from subsequent studies,35,36 the group of Yamamoto was 
eventually able to devise a suitable catalyst for the asymmetric 
bromocyclization of polyenes.46 After optimization, binol-based 
thiophosphoramide 68 was selected as the best catalyst in 
combination with DBDMH (Figure 4). As with Ishihara’s 
phosphite-urea catalyst, a dual activation of the halogenation 
reagent was postulated. However, here the Lewis base is the 
sulfur and not the phosphorous whilst the Brønsted acid is the 
triflimide. The Lewis basicity of the sulfur is essential as the 
analogous phosphoramide gave low yield and no selectivity. 
Additionally, both key moieties are located in close vicinity and 
inside the chiral pocket that is delineated by the large aromatic 
groups in the ortho positions of the binol backbone. 
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Figure 4 Activation of DBDMH by a thiophosphoramide 
Using only 5 mol% of catalyst 68 with DBDMH promoted the 
cyclization of homogeranylarenes 9 leading, after acidic 
treatment in most cases, to the brominated tricycles 10 with 
yields ranging from 44% to 98% and enantiomeric ratios up to 
97:3 (Scheme 26).  
 
Scheme 26 Asymmetric bromocyclization of homogeranylarenes 
When the same reaction conditions were applied to 
geranylbenzene, a mixture of endo- and exo-monocyclized 
products 49a and 49a’ were obtained in 82% combined yield 
and 84% ee for the former and only 26% ee for the latter 
(Scheme 27). In sharp contrast to what was observed by 
Ishihara with his phosphite-urea catalyst (Scheme 25), when 
applied to geranylphenols these conditions favor the formation 
of tricyclic products 50 with moderate to good yields and good 
enantiomeric excesses.  
 
Scheme 27 Asymmetric bromocyclization of various polyenes 
Moreover, for the substrate bearing a 2,4-dimethoxyphenol 
moiety, the intermediate carbocation was trapped by a C-C bond 
of the aromatic ring, yielding [6,5,6]-fused tricycle 69 rather 
than the corresponding oxygenated [6,6,6]-fused system. 
6. Total Synthesis of Halogenated 
Natural Products 
From the onset, the goal of the research on the halocyclization 
of polyenes was to mimic Nature in order to access structurally 
complex molecules. Thus, numerous efforts have been devoted 
to apply this strategy for the total synthesis of natural products 
incorporating halogen atoms.47  
6.1 Using NBS 
In 1977, the group of Gonzales started their synthesis of 
snyderol by cyclizing methyl farnesate 6 into diene 8 in 12% 
yield using NBS with copper(II) acetate (Scheme 28).48 
Reduction of the ester and bromination of the resulting allylic 
alcohol led to 70 that was then converted into snyderol by an 
aqueous acidic treatment. 
 
Scheme 28 First total synthesis of snyderol using NBS 
In 2014, McErlean undertook the synthesis of luzofuran, 
isolated from the red alga Laurencia luzonensis.49 
Phosphoramidite (S)-TCPT (56) was used to promote the 
bromocyclization of enantioenriched furanic alcohol 71 with 
NBS to directly access (+)-luzofuran (Scheme 29, eq.1).50 The 
latter was obtained alongside minor amount of its epimer 72, 
which could in turn be transformed into (–)-ancistrofuran (itself 
isolated from the defensive secretions of the West African 
termite Ancistrotermes cavithorax51) by debromination (Scheme 
29, eq. 2). 
 
Scheme 29 First total synthesis of Snyderol using NBS 
Although the target compounds were effectively obtained, both 
examples show the poor performance of NBS, even in the 
presence of a promoter, for bromo-carbocyclizations.  
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Scheme 30 Total synthesis of aplysistatin using TBCO for the key bromocyclization 
Hence, many groups turned their attention towards specially 
designed reagents such as TBCO or BDSB to improve the 
efficiency of the key cyclization step. 
6.2 TBCO 
To synthetize (–)-aplysistatin, an antineoplastic isolated form 
the sea hare Aplysia angasi,52Prestwich used TBCO as the 
promoter for the key bromocyclization.53 Cyclization of 
enantioenriched geranyl-γ-butyrolactone 73 with TBCO led to 
the desired tricycle 74 and its bromo-epimer in a combined 12% 
yield (Scheme 30). This mixture was then converted into (–)-
aplysistatin (and its bromo-epimer) by a selenation/oxidation/ 
elimination sequence in 93% yield. The pure natural product 
could be isolated from the epimer-mixture by HPLC. Although 
the yield of the cyclization is rather low and the desired 
diastereoisomer is the minor one formed, this route is, 
nevertheless, rather straightforward and avoids the use of 
stoichiometric amount of toxic mercury salt as previously 
reported by Hoye for the racemic synthesis of aplysistatin.54 
A TBCO-promoted bromocyclization was used by the group of 
Kato as the key step for the total synthesis of a series of 
molecules. In 1985, they reported the synthesis of both 
concinndiol55 and aplysin 2056 from a common precursor 
(Scheme 31).57 Using acetonitrile as the solvent favored the 
cyclization of geranylgeranate 75 initiated by TBCO and gave 
brominated bicylic product 76 in 20% yield (along with 30% of 
the monocyclic product). Epoxidation of the endo-cyclic double 
bond led to a 2:1 mixture of isomers 77:78 (Scheme 31, eq. 1). 
77 was selectively reduced with aluminum hydride to the 
corresponding allylic alcohol 79 which was converted into 
concinndiol in three steps (Scheme 31, eq. 2). Longer exposure 
to aluminum hydride of the other diastereoisomer 78 triggered 
the reduction of the ester and the opening of the oxirane to give 
aplysin-20 in one step (Scheme 31, eq. 3).  
A slightly modified strategy was then used for the total synthesis 
of pinnatol D58 and isoconcinndiol.59 Starting from farnesyl 
derivative 79, TBCO-promoted bromocyclization gave a 
complex mixture out of which the desired bicyclic product 80 
could be isolated in 30% yield as a 1:1 mixture of isomers 
(Scheme 32, eq. 1).60 Both the benzoate and the methyl ester 
were reduced to furnish the two corresponding 
diastereoisomeric diols, that were separated by 
chromatography. From diastereoisomer 81, pinnatol D could 
then be attained by a Grieco elimination. From pinnatol D, 
epoxidation followed by reduction with aluminum hydride gave 
conncindiol. Alternatively, after protection of the diol, regio- and 
stereo-selective hydroboration of the endocyclic double bond 
followed by oxidation installed the tertiary alcohol of 82 
(Scheme 32, eq. 2). Finally, a Grieco elimination was then 
performed to access isoconcinndiol. In order to access 
cyclocymopol,61 Tanaka used TBCO on dimethoxypheny-geranyl 
derivative 66g, which led to the desired methylene-
bromocyclohexane 67g in 35% yield (Scheme 33).62 Removal of 
both methyl groups was carried out in a two-step sequence, 
starting with a silver-mediated oxidation into a benzoquinone 
that was reduced with sodium hydrosulfite to give cyclocymopol 
in 20% yield. The TBCO-promoted bromocyclization protocol 
was applied to the analogous di-MOM-protected geranyl 
derivative 38.63 
 
Scheme 31 Total synthesis of concinndiol and aplysin 20 using TBCO for the key bromocyclization 
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Scheme 32 Total synthesis of pinnatol D and isoconcinndiol using TBCO for the key bromocyclization 
 
Scheme 33 Total synthesis of cyclocymopol and isocycmobarbatol using TBCO for the key bromocyclization 
In this case, concomitantly with the loss of a MOM group, 
tricyclic product 83 was obtained in 40% yield. Acidic cleavage 
of the remaining protecting group led to isocycmobarbatol32 in 
near quantitative yield. 
6.3 BDSB 
The development of BDSB by Snyder opened promising 
perspectives for targeting brominated natural products as first 
exemplified by its use for the synthesis of isocymobarbatol.21 
Compared to TBCO, BDSB proved to be far more efficient since 
the bromocyclization of compound 38 took place in only five 
minutes to give 83 with 74% yield (Scheme 34).  
 
Scheme 34 Total synthesis of isocycmobarbatol using BDSB for the key 
bromocyclization 
Shortly after, Snyder undertook the total synthesis of peyssonol 
A,64 whose relative configuration was unambiguously assigned 
by performing the same synthetic sequence starting from 
different trienes.23 The actual peyssonol A was obtained starting 
from triene 84 that was submitted to the action of BDSB to give 
tricyclic carbonate 85 in 56% yield (Scheme 34, eq. 1). 
Methanolysis followed by oxidation of the primary alcohol and 
elimination of the tertiary alcohol led to decaline 86 in 76% 
yield. The synthesis was completed by adding the aryl moiety as 
its lithium derivative followed by reduction of the benzylic 
alcohol, formylation and acidic cleavage of the MOM groups, 
furnishing peyssonol A in a 15% overall yield. In addition to the 
various isomers that were synthetized, a iodo-analogue was 
constructed using IDSI instead of BDSB and all the synthesized 
compounds were evaluated for their HIV-1 inhibition 
properties.65 To access peyssonoic acid A,66 a slightly different 
approach was chosen and the bromocyclization was performed 
on triene 87 that already incorporated the aryl moiety (Scheme 
35, eq. 2). This gave tetracycle 88 in 31% yield with a good 
chemoselectivity since the allyl group was untouched. The later 
was then fully oxidized to the carboxylic acid, then treatment 
with boron trichloride cleaved both ethers to deliver peyssonoic 
acid A. Snyder also disclosed the utility of BDSB to access various 
bromo-chamigrenes derivatives, albeit unnatural ones.67 
Krauss, decided to use BDSB on macrocylic triene 89 to trigger 
a transannular bromocyclization, via bromiranium 90, to access 
bromophycolides68 derivatives (Scheme 36). Macrocycle 89 was 
obtained as the S-enantiomer (ee 92%) using a regiospecific 
Sharpless asymmetric dihydroxylation and a Shiina 
macrocyclization as the key steps. 69 When submitted to BDSB in 
a highly polar media (addition of aqueous 1 M LiClO4 to the 
solvent) the major products obtained were allylic bromides 91 
and 91’.
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Scheme 35 Total synthesis of peyssonol A and peyssonoic acid A using BDSB for the key bromocyclization  
Yet, ca 20% of monocyclized compounds 92 and 93 were also 
obtained, the latter exhibiting a bromophycolides D skeleton 
with an exo-cyclic double bond.68a Unfortunately, the authors 
were unable to form the bromohydrin on the remaining double 
bond embedded in the macrocycle, which would have 
completed the total synthesis. 
7. Conclusion and Perspectives 
In more than fifty years after the initial report of a direct 
bromocyclization of a polyene by Van Tamelen, tremendous 
improvements have been achieved. The development of 
reagents such as BDSB allowed to increase yields by tenfold, 
thus making these transformations sufficiently efficient to 
tackle the synthesis of complex compounds, including polycyclic 
halogenated natural products. Additionally, following the 
seminal report by Ishihara in 2007, catalytic enantioselective 
versions have also been developed. Nevertheless, the vast 
majority of the literature on the topic deals with bromo-
cyclizations whilst iodocyclization remains 
rare,chlorocyclization even more scarce, without mentioning 
the fact that a direct fluorocyclization of polyene has yet to be 
described.70 Therefore, future developments should aim to 
overcome these limitations. 
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A.; Nguyen, H.; Gagné, M. R. J. Am. Chem. Soc. 2013, 135, 628. 
 
  
Synthesis Review / Short Review 
Template for SYNTHESIS © Thieme  Stuttgart · New York 2019-10-07 page 17 of 17 
Biosketches 
 
 
Kevin Cariou (left) after graduating from ChimieParisTech in 
2002, he received his PhD in 2006 from the University Pierre 
and Marie Curie (now Sorbonne University) in Paris (France) 
under the supervision of Prof. M. Malacria and L. Fensterbank, 
where he studied platinum- and gold-catalyzed 
transformations with a joint CNRS-Sanofi BDI fellowship. From 
2007 to 2009, including one-year as a Lavoisier fellowship 
holder, he worked as a postdoctoral researcher in the group of 
Prof. A. J. Frontier at the University of Rochester (NY, USA) in 
the field of total synthesis. He was appointed a Chargé de 
Recherche in 2009 at the CNRS at the ICSN in the team 
Synthesis and Methodology Applied to Research in 
Therapeutics (SMART) led by Dr R. H. Dodd. Since 2017, he has 
become the leader of the SMART team and his current research 
interest lie in the development of new synthetic methods, with 
a focus on iodine(III) reagents and nitrogen-rich building 
blocks, and their application toward the synthesis of 
biologically active molecules.  
 
Agathe D’Hollander (right) was born and raised in the North 
of France near Dunkerque and graduated (head of class) from 
the Ecole Nationale Supérieure de Chimie de Lille in 2013. She 
obtained her PhD in 2017 from the University of St Andrews 
(Scotland) under the joint supervision of Prof. N. J. Westwood 
(St Andrews), Prof. A.M. Thompson (Ninewells Hospital, 
Dundee, Scotland) and Prof. Sir D. P. Lane (A*STAR, Singapore) 
working on upregulators of the WTp53 protein. She joined the 
SMART team at the ICSN in 2017 to work on the development 
of carbapenemases inhibitors. 
 
Laure Peilleron (middle) was born and raised in Orléans, 
France. She obtained a Master’s degree in organic chemistry in 
2016 from both ChimieParisTech and Sorbonne University. 
She started her PhD studies in October 2016 at the ICSN, under 
the direction of Dr. Kevin Cariou to work on hypervalent 
iodine(III) mediated halogenation reactions. 
 
Stork, G.; Burgstahler, A. W . J. Am. Che m. Soc. 1 955, 7 7, 5068  
2 (a) Esche nmoser, A.; Ruzi cka, L.; Jeger, O. ; Arigoni, D. Helv. Chi m. Acta 19 55, 38, 1890. (b) Eschenmoser, A.; Arigoni, D. Helv. Chi m. Acta 2 005, 88, 3011.  
3 For key reviews on polyene cyclizations, see : (a) W. S. Johnson, Angew. Che m., Int. E d. Engl. 19 76, 15, 9. (b) Yoder, R. A.; Johnston, J. N. Che m. Rev. 2005, 1 05, 473 0. (c) Snyder, S. A.; Levinson, A. M. In Compr. Org. Synth., 2 nd e d.; Knochel, P., M olander, G. A., Eds. ; Elsevier: Amster dam, 2 014; 3 , 268. (d) Bauna ch, M. ; Franke, J.; Hertweck, C. Angew. Che m., Int. Ed. 2015, 5 4, 2604 . (e ) Ungarea n, C. N. ; Southgate, E. H .; Sarlah, D. Org. Biomol. Che m. 20 16, 14, 5454. (f) Barrett, A. G. M.; Ma, T. -K. ; Mies T. Synthesis 20 18, DOI : 10.1 055/s-0 037 -1610 382; Art ID: ss -20 18-z069 4-sr.  
4 (a) Faulkner, D. J. Tetrahedr on 197 7, 33, 14 21. (b) Gri bble, G. W. J. Nat. Prod . 1992, 55, 135 3. (c) Wa ng, B. -G. ; Gloer, J. B. ; Ji, N.-Y.; Z hao, J.-C. Che m. Rev. 20 13, 11 3, 3632 .  
5 Gribble, G. W. J. Chem. E duc. 2004, 8 1, 1441  
6 Chung, W.-J.; Vanderwal, C. D. Angew. Che m., Int. Ed. 2016, 5 5, 4396 .  
7 (a) Butler, A.; Carter-Franklin, J. N. Nat. Prod . Rep. 2 004, 2 1, 180. (b) Vaillancourt, F. H.; Yeh, E.; Vosburg, D. A. ; Garneau -Tsodikova, S.; Wal sh, C. T. Che m. Rev. 200 6, 106, 3 364. (c) Butler, A.; Moriah S. Nature 2 009, 46 0, 848. (d) Agarwal, V.; Miles, Z. D.; Winter, J. M.; E ustaqui o, A. S.; El Gamal, A. A.; Moore, B. S. Che m. Rev. 2 017, 11 7, 561 9.  
8 Kubanek, J.; Pr usak, A. C.; Snell, T. W.; Gie se, R. A.; Har dcastle, K. I.; Fairchil d, C. R.; Aalbersberg, W.; Raventos -Suare z, C.; Hay, M. E. Org. Lett. 20 05, 7, 52 61.  
9 Braddock 
10 For other reviews covering some of t hese aspects, see: Snyder, S. A.; Treitler, D. S.; Brucks , A. P. Aldrichi mica Act a. 2011, 44, 27.  
11 Van Tamelen, E. E. ; Hessler, E. J. Chem. Commun. 1966 , 411.  
12 Nasipuri, D.; Ray Cha udhuri, S. R. J. Che m. Soc. Perkin Trans I 19 75, 262 .  
13 Wolinsky, L. E. ; Faulkner, D. J. J. Org. Che m. 19 76, 41, 5 97.  
14 Kato, T.; Ichinose, I.; Kuma zawa, S.; Kitahara, Y. Bi oorg. Chem. 1 975, 4, 188.  
15 Kitahara, Y.; Kato, T.; I chinose, I. Che m. Lett., 197 6, 283  
16 Kato, T.; Ichinose, I. J. Che m. Soc. Perkin Trans I 198 0, 1051 .  
17 Barluenga, J.; G onza l´ez, J. M.; Ca mpos, P. J.; Ase nsio, G. Angew. Chem., I nt. Ed. Engl. 1 985, 2 4, 319.  
18 Barluenga, J.; G onza l´ez, J. M.; Ca mpos, P. J.; Ase nsio, G. Angew. Chem., I nt. Ed. Engl. 1 988, 2 7, 1546.  
19 Günther, H. J.; Jäger, V.; Skell, P. S. Tetrahedron Lett. 1977, 1 8, 2539.  
20 Barluenga, J.; Trincado, M.; Rubio, E. ; González, J. M. J. Am. Chem. Soc. 200 4, 126, 3 416.  
21 Snyder, S. A.; Treitler, D. S. Angew. Chem. , Int. Ed. 20 09, 48, 7 899.  
22 Snyder, S. A.; Treitler, D. S. Org. Synth. 2011, 8 8, 54.  
23 Snyder, S. A.; Treitler, D. S.; Brucks, A. P . J. Am. Che m. Soc. 2 010, 1 32, 143 03  
24 Marquet A.; Jacques. J. Tetrahedron Letters. 1959, 9,24.  
25 (a) Collado, I. G.; Mader o, J. G.; Massa net, G. M.; Luis, F. R. Tetrahedron Lett. 1990, 31,56 3. (b) Collado, I. G.;  
Madero, J. G.; Massanet, G. M. ; Lui s, F. R. J. Org. Chem. 1991, 5 6,358 7.  
26 Jain, T. C.; Banke, C. M.; M cCloekey, J. E. Tetrahedron 197 9, 36, 8 86.  
27 (a) Butler, A.; Walker, J. V. Chem. Rev. 1993, 9 3, 193 7. (b) Lat ham, J.; Brande nburger, E. ; Shepherd, S. A.; Me non, B. R. K.; Mi cklefield, J. Che m. Rev. 2018, 1 18, 232 .  
28 Carter-Franklin, J. N.; Parrish, J. D.; Tschirret-G uth, R. A.; Little, R. D.; Butler, A J. Am. Che m. Soc. 2 004, 1 26, 150 60.  
29 Ascheberg, C.; Bock, J.; Buß, F. ; Mück -Li chtenfeld, C.; Danil uc, C. G.; Bergander, K.; Diel mann, F.; Hennecke, U. Che m. - Eur. J. 20 17, 23, 1 1578.  
30 Yoshi mura, A.; Zhda nkin, V. V. Che m. Rev. 201 6, 116, 3 328.  
31 Grayfer, T. D.; Retailleau, P.; Dodd, R. H.; D uboi s, J.; Cariou, K. Org. Lett. 2017, 1 9, 476 6.  
32 Wall, M. E. ; Wani, M. C.; Manikumar, G.; Tayl or, H.; Hug hes, T. J.; Gaeta no, K. ; Gerwick, W. H .; McPhail, A. T.; M cPhail, D. R. J. Nat. Prod . 1989, 52, 109 2.  
33 Peilleron, L. ; Grayfer, T. D. ; Dubois, J.; Dodd, R. H.; Cari ou, K. Beilstein J. Org. Chem. 2 018, 14, 1103.  
34 Sakakura, A.; Ukai, A.; Ishihara, K. Nat ure 2007, 4 45, 900 .  
35 Sawamura, Y.; Nakatsuji, H .; Sakakura, A.; Ishihara, K. Che m. Sci. 20 13, 4, 41 81  
36 Sawamura, Y.; Nakatsuji, H .; Akakura, M.; Sakakura, A.; Ishihara, K. Chirality 2014, 26, 356 .  
37 Recsei, C.; M cErlean, C. S. P. Aust. J. Che m. 2015 , 68, 55 5.  
38 Samanta, R. C.; Yama mot o H. Che m. Eur. J. 201 5, 21, 11 976.  
39 Arnold, A. M.; Pöt hig, A.; Drees, M. ; Gulder, T . J. Am. Che m. Soc. 2 018, 14 0 , 4344  
40 For general reviews on ena ntiosele ctive polyene cyclisation, see re f 3e.  
41 For general reviews on this topic, se e: (a ) Denmark, S. E.; Kuester, W. E.; Burk, M. T. Angew. Che m., Int. Ed. 2 012, 51 , 1093 8. (b) Cheng, Y. A.; Y u, W. Z.; Ye ung, Y. -Y. Org. Biomol. Che m. 20 14, 12, 2 333. (c) Chen, J.; Zhou, L. Synthesi s 2014, 4 6, 586.  
42 For a highlight speci fically on this topi c, see: Che n, G.; Ma, S. Angew. Che m. Int. Ed. 2 010, 49, 8306.  
43 For key reviews specifi cally on this topic, se e: (a ) Cresswell, A. J.; Eey, S. T.-C.; D enmark, S. E. Angew. Che m., Int. Ed. 2 015, 5 4, 1564 2. (b) La ndry, M. L.; Burns, N. Z. Acc. Chem. Res. 20 18, 51, 1260.  
44 Sakakura, A.; Ishihara, K. Che m. Re c. 20 15, 15, 7 28.  
45 Sawamura, Y.; Og ura, Y.; Nakatsuji, H .; Sakakura, A.; Ishihara, K. Che m. Commun. 2 016, 52, 6068.  
46 Samanta, R. C.; Yama mot o H. J. Am. Che m. Soc. 2017, 1 39, 14 60.  
47 For seminal and rece nt reviews covering some aspe cts of this se ction, see: (a ) Faulkner, D. J. Pure Appl. Che m. 197 6, 48, 25 . (b) Ardkhea n, R.; Caput o, D. F. J.; Morrow, S. M.; Shi, H .; Xiong, Y.; Anderson, E. A. Che m. Soc. Rev. 2016, 4 5, 1557 a nd re ferences 3 f & 6.  
48 Gonzále z, A. G.; Martin, J. D.; Pére z, C.; Ramire z, M. A. Tetrahedron Lett. 1976, 17, 137 .  
49 Kuniyoshi, M.; Wa home, P. G .; Miono, T.; Ha shimoto, T.; Y okoyama, M .; Shrestha, K. L.; Higa, T. J. Nat. Prod. 2 005, 68 , 1314  
50 Recsei, C.; Chan, B.; M cErlean, C. S. P. J. Org. Che m. 20 14, 79, 8 80  
51 Baker, R.; Bri ner, P. H. ; Evans, D. A. J. Che m. Soc., Chem. Commun. 197 8, 410.  
52 Pettit, G.R.; Herald, C.L; Alle n, M.S.; Von Dreel e, R. B.; Vanell, L.D.; Ka o, J.P.Y.; Blake, W., J. Am. Che m. Soc., 197 7, 99, 26 2  
53 Shieh, H.-M .; Prestwich, G. D. Tetrahe dron Lett. 1982, 23, 4643.  
54 Hoye, T.R.; Kurth M.J., J. Am. Che m. Soc. , 1979, 101, 50 65–50 67. Hoye, T. R.; Caruso, A.J.; Dellarla, F.F. and Kurth, M .J., J. Am. Che m. Soc., 1 982, XX,  
55 Sims, J. J.; Lin, G. H. Y. ; Wing, R. M.; Feni cal, W. Chem. Commun. 1973 , 470.  
56 Yamamura Y.; Hirata, Y. Bull. Chem. Sot. Jpn. 1971, 4 4, 256 0.  
57 Yamaguchi, Y.; Uye hara, T.; Kato, T. Tetrahedron Lett. 1985, 26 , 343.  
58 Fukuzawa, A.; Miyamot o, M.; Kumagai, Y.; Abik o, A.; Takaya, Y.; Masamune, T. Che m. Lett. 198 5, 1259  
59 Howard, B.M .; Fenical, W. Phytochemi stry 1980, 19, 2 774  
60 Fujiwara, S.; Takeda, K.; Uyehara, K.; Kato, T. Che m. Lett. 1986 , 1763.  
61 (a) Hog berg, H.-E.; Thomson R. H.; Ki ng, T. J. J. Chem. Soc., Perkin Trans . 1 1976 , 1696. (b) McConnel, O. J.; Hughe s, P. A.; Targett, N. M. Phytoche mistry 1982, 21, 2139.  
62 Tanaka, A.; Sato, M.; Yamashita, K. Agric. Biol. Che m. 19 90, 54, 1 21.  
63 Tanaka, A.; Oritani, T. Biosci., Bi otechnol., Bioche m. 199 5, 59, 51 6.  
64 (a) Talpir, R.; Rudi, A.; Kashma n, Y.; Loya, Y.; Hizi, A. Tetrahe dron 19 94, 50, 4 179. (b) Loya, S.; Bakhanaskvili, M.; Ka shman, Y.; Hi zi, A. Arch. Bioche m. Biophys. 19 95, 31 6, 789.  
65 Treitler, D.S.; Li, Z.; Krystal, M.; Meanwell, N.A.; Snyder, S.A. Bi oorg. Med. Che m. Lett. 201 3, 23, 21 92.  
66 Lane, A. L. ; Mular, L. ; Drenkard, E. J.; Shearer, T. L.; Engel, S. ; Fredericq, S.; Fairchild, C. R. ; Prudhomme, J.; Le Roch, K.; Hay, M. E.; Aalbersberg, W.; Kubanek, J. Tetrahedron 20 10, 66, 4 55.  
67 Shen, M.; Kretschmer, M.; Brill, Z. G.; Snyder, S. A. Org. Lett. 2016, 18, 501 8.  
68 (a) Kubanek, J.; Pr usak, A. C.; Snell, T. W.; Gie se, R. A.; Fairchild, C. R.; Aalbersberg, W. ; Hay, M. H. J. Nat. Prod . 2006, 69, 731. (b) La ne, A. L.; Stout, E. P.; Li n, A.-.S.; Prudhomme, J.; Le Roch, K.; Fairchild, C. R.; Fran zblau, S. G. ; Hay, M. E.; Aalbersberg, W.; Kuba nek, J. J. Org. Che m. 2009 , 74, 273 6. (c) Lin, A . S.; Stout, E. P.; Prudhomme, J.; Le Roch, K .; Fairchild , C. R. ; Franzbla u, S. G.; Aalbersberg, W.; Hay, M . E. ; Kubanek, J. J. Nat. Prod. 2010, 7 3, 275 a nd reference 8.  
69 Lin, H.; Pochapsky, S. S.; Krauss, I. J. Org. Lett. 2011, 13 , 1222.  
70 Gagné propose d an elegant solution by the mea n of an ena ntiosele ctive Pt(II )-catalyzed cy clization of polyene that is termi nated by a fl uoro -de metallation with XeF 2, see: Cochrane, N. A.; Nguye n, H.; Gag né, M. R. J. Am. Che m. Soc . 20 13, 135 , 628.  
 
